Trevor J. Chaplick

• Represented AGCO Corporation (NYSE: AGCO) in the purchase of all equity of Appareo Systems, LLC. Represented AGCO, a worldwide manufacturer and distributer of agricultural machinery and technology, in the acquisition of Appareo, a leader in software and hardware development and manufacturing for the agricultural and aerospace industries.
• Represented Involvio in the sale to Cisco Systems. Involvio provides a software platform of education-focused products designed to improve student engagement for colleges and universities.
• Represented Major Medical Institution in Sale to Merck & Co. (NYSE: MRK). Represented a major medical institution in the sale of its equity interests to Merck & Co. (NYSE: MRK).
• Represented Earth Networks in the Sale to Advanced Environmental Monitoring and private equity fund Union Park Capital. Represented Earth Networks in a buyout by Advanced Environmental Monitoring and its sponsor private equity fund Union Park Capital. Earth Networks provides comprehensive and automated weather data solutions to a global base of customers. 
• Buyout of Lykan Bioscience LLC by WindRose Health Investors LLC. Represented Lykan Bioscience Holdings, LLC, in a buyout by private equity fund Windrose Health Investors LLC. Lykan Bioscience is a manufacturing services organization that provides production and logistics solutions for pharmaceutical and biotech companies focused on cell and gene therapies.
• Sale of Energy Management Business of Whisker Labs to Resideo Technologies, Inc. (NYSE:REZI). Represented Whisker Labs, Inc. in the sale of its energy management business to Resideo Technologies, Inc.
• Sale of Equity Interests of NEA in EPIX Therapeutics to KKR/Ajax Heath, LLC. Represented New Enterprise Associates (NEA) in the sale of its equity interests in EPIX Therapeutics, Inc. (“EPIX”) to Ajax Health, LLC, an affiliate of the private equity firm Kohlberg Kravis & Roberts (KKR). EPIX is a medical device company that designs and manufactures a catheter-based system for the treatment of patients with atrial fibrillation (AFIB).
• Represented SecurView, Inc. in the Sale of Controlling Equity Interests to RAG-Stiftung. Represented SecurView and the primary selling stockholders in the purchase of a controlling interest in Securview, a cybersecurity company, by the private equity fund RAG-Stiftung (RAG Foundation), through its investment company RAG-Stiftung Beteiligungsgesellschaft mbH (RSBG) based in Germany. The transaction involved complex cross border issues involving both Germany (buyer) and India (wholly-owned subsidiary of SecurView based in India).
• Sale of Luminaire LED to The Luminaires Group and private equity fund Sentinel Capital Partners V, L.P. Represented Luminaire LED, Inc. (Luminaire LED) in the sale of the company to The Luminaires Group and its financial sponsor private equity fund Sentinel Capital Partners V, L.P. (Sentinel). Luminaire LED provides vandal resistant lighting and other custom LED products.
• Sale of WeatherBug Consumer Business to xAd, Inc. Represented Earth Networks, Inc. in the sale of its WeatherBug Consumer Business to xAd, Inc. Earth Networks has the largest network in the world for weather, lightning and greenhouse gas monitoring.
• Acquisition of Whisker Labs by Earth Networks. Represented Earth Networks in the acquisition of and merger with Whisker Labs, a developer of energy sensing hardware and software that integrates non-connected devices for real time monitoring of energy consumption.
• Sale of the Greenbuild International Conference business of USGBC to Hanley Wood LLC. Represented the U.S. Green Building Council (USGBC) in the sale of the Greenbuild International Conference to private equity firm Hanley Wood LLC. The Greenbuild conference is the largest real estate convention in the U.S. and represented the largest asset of the USGBC.°
• Merger of Plateau Systems, Ltd. and SuccessFactors, Inc. (NYSE: SFSF). Represented Plateau Systems, Ltd., a provider of cloud-based talent management software, in its sale to and merger with SuccessFactors, Inc., a provider of business execution software solutions.°
• Merger of Trusted Computer Solutions and Raytheon Company (NYSE: RTN). Represented Trusted Computer Solutions (TCS) in its sale to and merger with Raytheon Company. TCS provides software and services that enable federal and civilian government agencies, NATO, and high-risk industries such as Financial Services, the ability to share and access information securely across multiple networks (including the most sensitive and classified networks). TCS’s solutions include the secure software uplink capabilities for drones used by the U.S. military and intelligence agencies.°
• Merger of Intellon Corporation (NASDAQ: ITLN) with Atheros Communications, Inc. (NASDAQ: ATHR). Represented Intellon Corporation in its sale to and merger with Atheros Communications, Inc. Representation included serving as general outside counsel for Intellon for several years having guided the company through both its initial public offering in 2007 and its ultimate sale to and merger with Atheros. Intellon designs and sells integrated circuits for home networking, networked entertainment, commercial and Smart Grid applications.°
• Buyout of Morningside Management LLC by Harrison Street Real Estate Capital (NYSE: HSRE). Represented Morningside Management LLC in a buyout by private equity firm Harrison Street Real Estate Capital (HSRE) that resulted in HSRE acquiring a 90% equity interest in Morningside with retention by management of a minority interest. Morningside is the largest independent operator in the Mid-Atlantic of extended care living facilities.°
• Merger of Netcordia with Infoblox, Inc. (NYSE:BLOX). Represented Netcordia in its sale to and merger with Infoblox, Inc. Netcordia is a developer of software and hardware for analyzing IT systems.°
• Merger of Wireless Valley Communications, Inc. with Motorola (NYSE:MOT). Represented Wireless Valley Communications, Inc. in its sale to and merger with Motorola, Inc. Wireless Valley Communications is a developer of software that sets up and manages wireless networks.°
• Acquisition by Microchip Technology Incorporated (NASDAQ: MCHP) of Intenco, S.A. Represented Microchip Technology Incorporated in its acquisition of Intenco, S.A., a semiconductor company based in Switzerland.°
• Multiple International Acquisitions by US Web (NASDAQ: USWB). Represented US Web, a website development firm, in all of its international acquisitions which were central to its growth strategy. Served as lead counsel for US Web in acquisitions effected in numerous countries including the U.K., France, Belgium, Germany and Switzerland.°
• Sale of ConnectYourCare Company LLC to Express Scripts Holding Company (NASDAQ:ESRX). Represented ConnectYourCare LLC in its sale to Express Scripts Holding Company. ConnectYourCare is a consumer-directed health plan account administrator.°
• Acquisition of AnchorChips by Cypress Semiconductor Corporation (NASDAQ: CY). Represented Cypress Semiconductor Corporation in its acquisition of Anchor Chips. Anchor Chips is a developer of microcontroller chips for high-speed Universal Serial Bus (USB) connections.°
• Merger of Access Health, Inc. (NASDAQ:ACCS) with McKesson Corporation (NYSE:MCK). Represented Access Health, Inc. in the sale to and merger with McKesson Corporation. Access Health is a leading provider of personal health management products and services to the health care industry.°
• Acquisition of InterQual, Inc. by Access Health, Inc. (NASDAQ:ACCS). Represented Access Health in the acquisition of and merger with InterQual, Inc. InterQual is a leading provider of clinical decision support criteria and systems to health care insurers, plans and providers.°
• Acquisition of Informed Access Systems by Access Health, Inc. (NASDAQ: ACCS). Represented Access Health in the acquisition of and merger with Informed Access Systems, Inc. Informed Access Systems is a health information services company.°
• Acquisition of Industrial Systems, Inc. by Aspen Technology, Inc. (NASDAQ:AZPN).Represented Aspen Technology in the acquisition of and merger with Industrial Systems, Inc. Aspen Technologies is a provider of software and services for the process industry. Industrial Systems is a supplier of open systems Process Information Management (PIM) software for large-scale process manufacturing environments.°
• Acquisition of the FPGA Semiconductor Business from Texas Instruments (NASDAQ:TSN) by Actel Corporation (NASDAQ:ATCL). Represented Actel Corporation in the acquisition of the antifuse field programmable gate array (FPGA) business from Texas Instruments.°
• Represented Friedman Billings Ramsey as financial advisor in the sale of Businesses. Represented Friedman Billings Ramsey (FBR) as financial advisor to (i) Aether Systems, Inc. (NASDAQ:AETH) in the sale of its transportation business to Platinum Equity Capital Partners, L.P., and (ii) TeleCommunication Systems, Inc. (NASDAQ:TSYS) in its acquisition of the Enterprise Mobility Solutions division of Aether Systems, Inc. (NASDAQ:AETH).°

Public Offerings

• Secondary Public Offering of ChannelAdvisor Corporation (NYSE:ECOM). Represented the institutional selling stockholders in the public offering by ChannelAdvisor Corporation ($195.5 million).°
• Initial Public Offering of Intellon Corporation (NASDAQ:ITLN). Represented Intellon Corporation in its initial public offering ($51 million).°
• Secondary Public Offering of Eagle Test Systems (NASDAQ:EGLT). Represented the underwriters (Banc of America, Lehman Brothers and Deutsche Bank) in the follow-on public offering of Eagle Test Systems ($105 million).°
• Initial Public Offering of Luna Innovations (NASDAQ:LUNA). Represented Luna Innovations in its initial public offering ($21 million).°
• Initial Public Offering of Eagle Test Systems (NASDAQ:EGLT). Represented the underwriters (Banc of America and Lehman Brothers) in the initial public offering of Eagle Test Systems ($100 million).°
• Secondary Public Offering of Rudolph Technologies, Inc. (NASDAQ:RTEC). Represented Rudolph Technologies, Inc. in its follow-on public offering ($158 million).°
• Initial Public Offering of Rudolph Technologies, Inc. (NASDAQ:RTEC). Represented Rudolph Technologies, Inc. in its initial public offering ($77 million).°
• Secondary Public Offering of Maxygen, Inc. (NASDAQ:MAXY). Represented the underwriters (Goldman, Sachs & Co., Robertson Stephens, Credit Suisse First Boston) in the follow-on public offering of Maxygen, Inc. ($146 million).°
• Initial Public Offering of Maxygen, Inc. (NASDAQ:MAXY). Represented the underwriters (Goldman, Sachs & Co., Robertson Stephens) in the initial public offering of Maxygen, Inc. ($110 million).°
• Initial Public Offering of SmartDisk Corporation (NASDAQ:SMDK). Represented the underwriters (Robertson Stephens, Hambrecht & Quist, Piper Jaffray) in the initial public offering of SmartDisk Corporation ($39 million).°
• Initial Public Offering of GlobeSpan, Inc. (NASDAQ:GSPN). Represented the underwriters (BancBoston Robertson Stephens, Donaldson Lufkin & Jenrette) in the initial public offering of GlobeSpan, Inc. ($56 million).°
• Initial Public Offering of At Home Corporation (NASDAQ:ATHM). Represented the underwriters (Morgan Stanley, Merrill Lynch, Alex Brown, Hambrecht & Quist) in the initial public offering of At Home Corporation (aka @Home Network) ($88 million).°
• Initial Public Offering of Coinstar, Inc. (NASDAQ:CSTR). Represented the underwriters (Smith Barney, Hambrecht & Quist) in the initial public offering of Coinstar, Inc. ($31.5 million).°
• Secondary Public Offering of Anergen, Inc. (NASDAQ:ANRG). Represented Anergen, Inc. in its follow-on public offering ($15 million).°
• Initial Public Offering of CellNet Data Systems, Inc. (NASDAQ:CNDS). Represented CellNet Data Systems, Inc. in its initial public offering ($100 million).°
• Secondary Public Offering of Access Health, Inc. (NASDAQ:ACCS). Represented Access Health, Inc. in its follow-on public offering ($100 million).°
• Initial Public Offering of Clarify, Inc. (NASDAQ:CLFY). Represented the underwriters (Alex Brown) in the initial public offering of Clarify, Inc. ($30 million).°
• Secondary Public Offering of Ventana Medical Systems, Inc. (NASDAQ:VMSI). Represented Ventana Medical Systems, Inc. in its follow-on public offering ($50 million).°
• Initial Public Offering of Ventana Medical Systems, Inc. (NASDAQ:VMSI). Represented Ventana Medical Systems, Inc. in its initial public offering ($25 million).°
• Registered Direct Offering of Anergen, Inc. (NASDAQ:ANRG). Represented Anergen, Inc. in the registered direct offering of common stock to Warburg Pincus Ventures, L.P. ($15 million).°

144A Offerings

• Common Stock of DataPath, Inc. Represented Friedman Billings Ramsey as the placement agent in the 144A offering of Common Stock of DataPath, Inc. ($350 million).°
• Senior Discount Notes of DIVA Systems, Inc. Represented DIVA Systems, Inc. in the 144A offering of Senior Discount Notes ($463 million).°
• Senior Discount Notes of Covad Communications Group, Inc. Represented Covad Communications Group Inc. in the 144A offering of Senior Discount Notes ($260 million).°
  Convertible Subordinated Notes of Level One Communications, Incorporated. Represented Level One Communications, Incorporated in the 144A offering of Convertible Subordinated Notes ($115 million).°
• Senior Discount Notes of CellNet Data Systems, Inc. Represented CellNet Data Systems, Inc. in the sale of Senior Discount Notes ($235 million).°
• Subordinated Discount Notes of DIVA Systems, Inc. Represented DIVA Systems, Inc. in the 144A offering of Senior Discount Notes ($47 million).°

PIPEs, Registered Direct Offerings and CMPOs

Trevor has represented institutional investors and companies in numerous private and public investments, including private investments in public equity (PIPEs), registered direct offerings, and confidentially marketed public offerings (CMPOs). Representative examples include:

• Sale of Common Stock in Sorrento Therapeutics (Nasdaq: SRNE). Represented a major medical institution in the purchase of shares of common stock in Sorrento Therapeutics (Nasdaq: SRNE) as part of an exclusive licensing transaction.
• Sale of Common Stock in Addex Therapeutics Ltd. (SIX Swiss Exchange:ADXN). Represented the lead institutional investor in the investment of common stock in Addex Therapeutics Ltd., a corporation based in Switzerland that is publicly traded on the SIX Swiss Exchange (ADXN). Addex Pharmaceuticals focuses on oral small molecule allosteric modulation-based drug discovery and development against diseases with high unmet medical needs, including Parkinson’s disease and dystonia.
• Sale of Series E Convertible Preferred Stock of Cascadian Pharmaceuticals, Inc. (NASDAQ:CASC). Represented the lead institutional investor in the CMPO of Series E Convertible Preferred Stock by Cascadian Pharmaceuticals, Inc. ($82.5 million).
• Sale of Common Stock and Warrants of Achaogen, Inc. (NASDAQ:AKAO). Represented the lead institutional investor in the PIPEs issuance of common stock and warrants by Achaogen, Inc. ($25 million).
• Sale of Common Stock and Warrants of MEDIAN Technologies (ALMDT.PA). Represented the lead institutional investor in the PIPEs issuance of common stock and warrants of MEDIAN Technologies, a French company which trades on the Euronext Paris Alternext Market (€20 million) (September 2014) and €19.8 million (July 2015).°
• Series B Preferred Stock Sale of Cell Genesys, Inc. (NASDAQ:CEGE). Represented Cell Genesys in the PIPEs issuance of Series B Preferred Stock ($20 million).°
• Sale of Common Stock and Warrants of Champions Oncology, Inc. (NASDAQ:CSBR). Represented the lead institutional investor in the PIPEs issuance of common stock and warrants by Champions Oncology, Inc. ($14 million).°
• Sale of Common Stock and Warrants of Strongbridge Biopharma plc (NASDAQ:SBBP). Represented the lead institutional investor in the PIPEs issuance of common stock and warrants by Strongbridge Biopharma plc ($38.5 million (2015)° and $35 million (2016)).

Trevor has represented entrepreneurs, companies and investors in hundreds of private financings for control and minority positions in both the U.S. and in many cross-border transactions including in the U.K., India, China, France, Canada, and Sweden. Investors he has represented in structuring private equity and venture capital financings include: Accuitive Medical Ventures; Andreessen Horowitz; Cargill Ventures; Carlyle Ventures; Core Capital; Draper Atlantic; Inflection Point Venture Partners; International Finance Corporation; Institutional Venture Partners; New Enterprise Associates; Novak Biddle Venture Partners; Paladin Capital Group; Storm Ventures; Valhalla Partners; Warburg Pincus; and WWC Capital.

Recent representative investment transactions include:

• Represented and served as lead attorney for Andreessen Horowitz in the $350 financing of Flow, a residential real estate company; the financing is considered to be one of the largest financings of a startup in the U.S.
• Represented Andreessen Horowitz in the financing of UnitedMasters, an independent music distribution platform. The financing was led by Apple.
• Represented private equity firm DRI Healthcare Trust (TSX: DHT.UN) in a synthetic revenue interest purchase with CTI BioPharma Corp. (Nasdaq: CTIC) totaling up to $135 million in funding for CTI with (i) $50 million in secured debt, (ii) $60 million to purchase a tiered royalty on sales of pacrinitib upon product approval by the FDA, and (iii) certain milestone royalty payments.
• Represented the Icahn School of Medicine in the licensing of certain rights in two separate transactions involving Renalytix PLC and LungLife AI, Inc. that were each separately listed on the Alternative Investment Market (AIM) of the London Stock Exchange. Renalytix (LSE: RENX) (Nasdaq: RNLX) develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. LungLife AI (LSE: LLAI) is a diagnostic company focused on the early detection of lung cancer from blood samples enhanced by artificial intelligence.
• Represented the Icahn School of Medicine at Mount Sinai in the spinout of patents and technology and formation of Amathus Therapeutics, Inc. The financing was led by Sanofi Genzyme BioVentures for up to approximately $45 million in financing proceeds subject to certain milestones. Amathus Therapeutics develops small-molecule therapeutics for the treatment of diseases and disorders caused primarily by lysosomal dysfunction.
• Represented the Icahn School of Medicine at Mount Sinai in the spinout of intellectual property to Sorrento Therapeutics, Inc. (NASDAQ: SNRE) that included (i) an exclusive license agreement from Mount Sinai for a collection of antibodies having SARS-CoV-2 neutralizing properties, and (ii) definitive agreements for the purchase of and registration rights for shares of common stock from Sorrento.
• Represented New Enterprise Associates and Andreessen Horowitz in the investment Yubico, A.B., a corporation based in Sweden that is a leading provider of authentication and encryption hardware for the modern web.
• Represented private equity fund GRI in the recapitalization and a funding of Fugue, Inc.
• Represented Involvio in a preferred unit financing led by Cisco Ventures. Involvio has created an application and software platform for student engagement within colleges and universities
• Represented New Enterprise Associates in a $44 million preferred stock financing of Annexon Biosciences, a biopharmaceutical company that develops therapeutic solutions to treat neurodegenerative disorders.
• Represented New Enterprise Associates in a $100 million+ preferred stock financing of Adaptimmune Limited, a biotechnology company based in the UK that has employed T-cell therapy to treat cancer and infectious disease; the financing at the time was considered to be the largest financing of a private biotechnology company in U.K. history°
• Represented Transamerica Ventures Fund and Delta Partners as the lead investors in the US$50 million preferred stock financing of CipherCloud, network security company based in Silicon Valley.°

°The above representations were handled by Mr. Chaplick prior to his joining Greenberg Traurig, LLP.

• Trevor serves as an Adjunct Professor of Law at American University Washington College of Law

Trevor has been recognized in Chambers USA Guide, Corporate / M&A & Private Equity, 2010-2023, The Best Lawyers in America, 2008-2024 in Washington DC and was named Lawyer of the Year (venture capital) for 2023, Super Lawyers in 2010-2023, and the “DC Area’s Top Deal Making Attorneys” in the Legal Times in 2006 (the only time in the last ten years the Legal Times has ranked the top ten deal lawyers in Washington, DC).

Chambers and Other Rating Services Recognition of the Transactional Experience and Expertise of Trevor Chaplick:

• In 2011, Chambers described the Washington, DC practice led by Trevor Chaplick in the District of Columbia Corporate M&A/Private Equity section of Chambers USA as a “compact but impressive team [that] works for companies and investors on M&A, private equity investments, venture financings, IPOs and restructuring matters.” In addition, Trevor was named as a “Key Individual” in this publication and recognized as “a very can-do attorney: he will find a way forward for you, he really wants to serve the client and will put you first.”
• In 2012, Chambers USA described the Washington, DC practice led by Trevor Chaplick as an “all-around corporate practice [that] has the breadth and depth to advise on M&A, private equity and capital market transactions at a regional, national and international level. A key deal for the group in the past year has been the representation of Trusted Computer Solutions in its sale to Raytheon.” Chambers quoted clients’ experience with Mr. Chaplick: "The group has provided our members with excellent information and resources on current issues and is wonderful to work with." Chambers recognized Mr. Chaplick as a Chambers-rated “Key Individual” who is a department head and “has a keen interest in the Indian business market and has worked on numerous deals there in the last few years. Clients highlight his "fantastic knowledge, depth and experience." Among his recent engagements, he advised Plateau Systems, a provider of cloud-based talent management software, on its $311 million sale to SuccessFactors.”
• In 2015, Chambers USA described the Washington, DC practice led by Trevor Chaplick as “acts for companies and investors on transactions at all stages of the corporate life cycle and also assists with corporate governance issues. Has a broad industry reach, with clients in the energy, life sciences, technology and real estate sectors.” Chambers quoted clients’ experience with Mr. Chaplick: "The relationship is excellent. We're very happy with them as our legal counsel. The service has been phenomenal." Chambers recognized Mr. Chaplick as a Chambers-rated “Key Individual” and was recognized by clients as “a man of multiple talents," and "very hard-working, meticulous and detail-oriented."
• In 2017 Chambers USA observed that Trevor Chaplick is well respected by sources, who remark that he is "an excellent lawyer, an extremely zealous advocate for his clients and he really gets to know and understand the business issues." He is well known for his venture capital work, as well as M&A and private equity deals.
• In 2019 Chambers USA stated that Trevor Chaplick is considered an "excellent lawyer" with a "sound business head" who is "thorough and professional." He handles a wide range of transactional matters, including M&A, as well as investments and financings.
• In 2022 Chambers USA noted that Trevor Chaplick has a robust cross-border practice which sees him advise on matters such as M&A and financings. "Trevor is very strong. He understands both the black letter law and business risk."

Awards and Recognitions

• Listed, The Best Lawyers in America, Venture Capital Law, 2008-2024; Lawyer of the Year (venture capital), 2023
• Listed, Thomson Reuters, "Stand-Out Lawyers," 2023-2024
• Listed, Super Lawyers magazine, Washington DC Super Lawyers, 2010-2023
• Listed, Chambers USA Guide, Corporate / M&A & Private Equity, 2010-2023
• Listed, The Legal 500 United States, M&A/Corporate and Commercial - Venture Capital and Emerging Companies, 2021
• Listed, "D.C. Area’s Top Deal-Making Attorneys," The Legal Times, 2006

• Counsel to the Independent Commission on the Los Angeles Police Department, 1990-1991
• Chairman, Board of Directors, Venture Capital Fund of the State of Maryland, 2003-2012
• Board of Directors, Mid-Atlantic Venture Association, 2010-2011
• Board of Directors, Bridgeborn, Inc., 2007–2011
• Board of Directors, Washington, DC Chapter of TiE, the not-for-profit global network of entrepreneurs, 2008-2010
• Board of Trustees, Fairfax County Public Schools Education Foundation, 2003-2004
• Member, American Bar Association
• Member, District of Columbia Bar Association
• Member, Virginia State Bar Association